MedTrace Logo

Predictability of Gestational Diabetes Mellitus in First and Second Trimester

NCT02035059 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 820

Last updated 2019-04-26

No results posted yet for this study

Summary

The objective of the study is, if an early oral glucose tolerance test combined with maternal history, condition and multiple biomarker analysis can be used to detect gestational diabetes mellitus in the first trimester (12-14 weeks of gestation).

Conditions

  • Pregnancy
  • Gestational Diabetes Mellitus

Sponsors & Collaborators

  • University Hospital, Zürich

    collaborator OTHER

  • Cantonal Hospital of Aarau, Switzerland

    collaborator OTHER

  • Vienna General Hospital

    collaborator OTHER

  • Paracelsus Medical University

    collaborator OTHER

  • University Hospital Freiburg

    collaborator OTHER

  • University Hospital, Basel, Switzerland

    lead OTHER

Principal Investigators

  • Evelyn Huhn, MD · Women's Hospital, University Basel

  • Irene Hösli, MD · Women's Hospital, University Basel

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-05-01
Primary Completion
2018-12-31
Completion
2018-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02035059 on ClinicalTrials.gov